C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/4545 (2006.01) A61P 31/12 (2006.01)
Patent
CA 2671460
The present invention relates to 4-[3-(1,1-difluoroethyl)-5-methyl-4H-1,2,4-triazol- 4-yl]-1-{(1R,3R)-3-(3,5-difluorophenyl)-1-methyl-3-[1-(methylsulfonyl).rho.iperidin-4- yl]propyl}piperidine formula (I): or a pharmaceutically acceptable salt thereof, as well as processes for the preparation of this compound and its use in the treatment of CCR5 disease states.
La présente invention concerne une 4-[3-(l,l-difluoroéthyl)-5-méthyl-4H-l,2,4-triazol-4-yl]-l-{(lJR,3i?)-3-(3,5-difluorophényl)-l-méthyl-3-[l-(méthylsulfonyl).rho.ipéridin-4-yl]propyl}pipéridine (I) : ou l'un de ses sels acceptables d'un point de vue pharmaceutique, ainsi que des procédés de préparation de ce composé et son utilisation dans le traitement d'états pathologiques du CCR5.
Faull Alan Wellington
Swallow Steven
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Piperidine derivative used for treating chemokine receptor 5... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivative used for treating chemokine receptor 5..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivative used for treating chemokine receptor 5... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1989214